Clinical Trials Directory

Trials / Completed

CompletedNCT02892591

Cannabis Versus Oxycodone for Pain Relief

A Double-Blind, Placebo-Controlled Crossover Study Comparing the Analgesic Efficacy of Cannabis Versus Oxycodone

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This study investigates the ability of cannabis to reduce chronic back and neck pain and to reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone and a placebo.

Detailed description

This study investigates the ability of cannabis to reduce chronic back and neck pain and to reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone and a placebo. Some inclusion/exclusion criteria are purposely omitted at this time to preserve scientific integrity. They will be included after the trial is complete.

Conditions

Interventions

TypeNameDescription
DRUGCannabisvaporized plant material
DRUGOxycodoneoral capsule
DRUGPlacebo for Cannabisvaporized placebo plant material
DRUGPlacebo for Oxycodoneoral placebo capsule

Timeline

Start date
2017-06-01
Primary completion
2023-06-07
Completion
2023-06-07
First posted
2016-09-08
Last updated
2024-02-22

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02892591. Inclusion in this directory is not an endorsement.

Cannabis Versus Oxycodone for Pain Relief (NCT02892591) · Clinical Trials Directory